2 completed, 1 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow pactimibe: new trials by email Literature Review of pactimibe trials Research Report on pactimibe
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE. Pactimibe sulfate - Atherosclerosis, Heterozygous Familial Hypercholesterolemia | Phase 2 / Phase 3 | Terminated | Daiichi Sankyo | 796 | 2004-02-01 | 2012-01-18 |
| Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease Pactimibe, CS-505 - Coronary Heart Disease | Phase 2 | Completed | Daiichi Sankyo | 534 | 2002-11-01 | 2007-09-11 |
| Efficacy and Safety of Pactimibe in Patients With Atherosclerosis Pactimibe - Atherosclerosis | Phase 2 | Completed | Sankyo Pharma Gmbh | 200 | 2002-09-01 | 2007-03-28 |
Atherosclerosis (3) · Coronary Disease (1)
Daiichi Sankyo (2) · Sankyo Pharma Gmbh (1)
United States (2) · Canada (1) · Germany (1) · Israel (1) · Netherlands (1) · Norway (1) · South Africa (1) · Spain (1) · Sweden (1) · United Kingdom (1)